| Name | Title | Contact Details |
|---|
Described as a vacation rental investors best friend, IntelliHost gives hosts their unique listings Airbnb search metric data to improve their listings and make thousands of dollars more with the same properties.
Aries Data Collections is a Mount Kisco, NY-based company in the Business Services sector.
Helbraun Levey is a law firm located in New York City, focusing on legal and licensing services for the hospitality and cannabis industries. Founded in 2005 by David Helbraun, the firm combines extensive experience with a deep understanding of these sectors to provide tailored solutions for its clients. Helbraun Levey aims to deliver exceptional legal support, drawing from its founders background in hospitality. The firm offers a variety of services, including legal assistance for bars, restaurants, hotels, and food and beverage outlets. This encompasses obtaining necessary licenses, corporate formation, financing, and business expansion. In the cannabis sector, Helbraun Levey supports entrepreneurs with capital raising, real estate selection, trademark registration, and compliance with employment law. Additionally, the firms Corporate Law Group specializes in drafting and negotiating various agreements, including partnership and licensing agreements. Helbraun Levey serves a diverse clientele, including first-time entrepreneurs, multi-unit operators, and established hotel chains, positioning itself as a key legal partner in these dynamic industries.
Cirrus Real Estate Partners is a real estate investment firm that focuses on value-based investment approach grounded in a deep and granular understanding of the base factors which drive real estate performance.
AmpliPhi Biosciences Corporation (NYSEMKT: APHB) is a biotechnology company focused on the development and commercialization of novel bacteriophage-based antibacterial therapeutics. AmpliPhi`s product development programs target infections that are often resistant to existing antibiotic treatments. AmpliPhi is collaborating with a number of leading organizations, including Intrexon Corporation (NYSE: XON), the U.S. Army, The Royal Brompton Hospital in London, UK and UK-based University of Leicester, to rapidly advance bacteriophage-based therapies.